Power successful drug development with reliable and flexible medical writing
Regulatory writing
Strategic regulatory writing delivering submission‑ready documentation for FDA, EMA, and MHRA, from early designations to INDs, NDAs, and BLAs, accelerating reviews, reducing questions, and improving first‑time approval outcomes.
More about this service
Clinical writing
High‑quality clinical writing delivering clear, submission‑ready documents, from Clinical Trial Protocols to Investigator’s Brochures, keeping studies on track, reducing rework, and maintaining momentum across every stage of drug development.
More about this service
Nonclinical Writing
High‑quality nonclinical medical writing that brings clarity, consistency, and regulatory confidence to early development, helping your program progress smoothly toward first‑time IND or CTA approval.
More about this service
Medical Communications
Insight-led medical communications that transform complex data into clear, compelling scientific narratives, supporting publication, presentation, and engagement across journals, conferences, and diverse scientific audiences.
More about this serviceClinical and regulatory medical writing is essential in advancing your research and drug development. But not every biotech team has the in-house capacity to meet the necessary standards or timelines.
With Morula Health’s medical writing services, you’ll work with an experienced team assigned specifically for you and your research. Through our proven process, you’ll get the regulatory documents you need at the right time and standard to drive your research forwards.
How Morula Health saved a US biotech time and resources on a complex Phase 2 CSR
Morula Health supported a US biotech with the delivery of a complex Phase 2 Clinical Study Report. Our specialist clinical writers applied therapeutic and document‑level expertise to meet tight timelines while maintaining clarity, accuracy, and regulatory alignment.
Find out more
Breaking Barriers: Facilitating FDA Approval
A case study of streamlining IND submission for a leading South Korean pharma company
Redefining Therapeutic Potential: Large Oncology IND Submission
How a small, consistent team of highly experienced medical writers can impact an IND submission.
Spend less time explaining what you need and more time getting results with our team of highly experienced medical writers.
Trust in experienced Project Managers and Quality Control Experts to get you the documents you need when you need them to keep your research moving.
It was a great pleasure working with Morula Health’s Project Manager and Medical Writer on our IMPD. The team responded in a timely manner, and 100% of the project was delivered on time.
Looking Ahead to ESMO 2026: Supporting the Next Generation of Oncology Innovation
As ESMO 2026 approaches, oncology remains one of the most dynamic areas of drug development. From precision medicine and antibody-drug conjugates to radiopharmaceuticals and AI-driven…
Find out more
From China to Global Markets: Preparing Biotech Assets for FDA and EMA
Explore the growing role of China-originated biotech assets and why early documentation strategy is key to global regulatory success.
Find out more
Key Insights from the EMWA 2026 Conference in Barcelona
Get the latest key insights from the EMWA 2026 event, where leaders shared their thoughts on the future of medical writing in Barcelona.
Find out more